The United Kingdom Ophthalmology Devices Market is anticipated to grow with a CAGR of 5% during the forecast period.
The COVID-19 pandemic affected healthcare systems and interrupted usual care in many healthcare facilities, exposing vulnerable patients to significant risks. The pandemic significantly impacted the ophthalmology devices market. For instance, according to a study published by the British and Irish Orthoptic Journal in March 2021, it was observed that during the first peak of the pandemic, outpatient clinic appointments were reduced by 87.2%, ophthalmic surgery by 90.9%, outpatient referrals to ophthalmology by 50.2%, and ward reviews by 50%. In addition, as per the same source, 1,377 canceled appointments were recorded, and 6.8% of those were deemed teleophthalmology-eligible. Thus, the COVID-19 pandemic severely curtailed the ophthalmology service's clinical activity. In the post-pandemic period, routine ophthalmic procedures are being normally conducted. Hence the market studied is expected to have stable growth during the forecast period of the study.
Certain factors propelling the market growth are demographic shifts, the increasing prevalence of eye diseases, and technological advancements in ophthalmic devices. For instance, an article published by Eye Journal in October 2021 stated that when a prospective cross-sectional study was carried out on participants in homeless shelters in Cardiff, United Kingdom, the findings indicated a significant disparity in ocular health, visual acuity, and refractive error amongst the homeless in comparison with the general population. The burden of eye diseases among the target population is expected to raise the demand for early diagnosis, which is likely to increase the demand for ophthalmology devices, thereby boosting market growth.
Furthermore, according to the data from the Association of British Dispensing Opticians (ABDO) in October 2022, ophthalmology was the busiest outpatient specialty in the NHS of the United Kingdom, and almost 633,000 people were waiting for NHS ophthalmology appointments in May 2022. The source also stated that more than 2 million people are at risk of vision loss due to glaucoma. An estimated 1,390,000 people are living with ocular hypertension, and a further 708,000 are living with glaucoma in the United Kingdom in 2022. Hence, the high prevalence of eye disorders in the United Kingdom and its rising burden is expected to enhance the market growth.
Moreover, key developments by major market players are also boosting market growth. For instance, in November 2021, Grafton Optical, a United Kingdom-based company, launched two new ophthalmic devices FundusVue camera and the NFC-600 non-mydriatic retinal camera. The NFC-600 non-mydriatic retinal camera’s key features include high-quality retinal images, portability, and connectivity. The FundusVue non-mydriatic fundus camera is designed to aid practitioners in diagnosing retinal diseases such as diabetic retinopathy, age-related macular degeneration (AMD), and glaucoma. Furthermore, in July 2021, Johnson & Johnson Vision introduced VERITAS Vision System, next-generation phacoemulsification (phaco) system designed to address three critical areas: patient safety, surgeon efficiency, and comfort in Europe, including the United Kingdom.
Hence, factors such as the rising prevalence of ophthalmic disorders and increasing key developments by major market players are boosting market growth. However, the risk associated with ophthalmic procedures is likely to restrain the market growth.
The optical coherence tomography (OCT) segment in the market studied is expected to be driven due to the growing burden of glaucoma and retinal diseases and the rising focus of key players. For instance, according to the statistics published by Glaucoma UK, in the International Glaucoma Association Report and Financial Statements year ended 31st July 2021, it was predicted that the number of people living with glaucoma will increase by 31% in the United Kingdom by 2035. Additionally, as per the article published by City, University of London, in May 2022, glaucoma affected around 2% of people aged over 40 years and almost 10% of those over 75 years, leading to more than a million hospital visits every year. Thus, a significantly high glaucoma burden on the country’s healthcare infrastructure is expected to drive the market. In addition, as per the same source, optical coherence tomography (OCT) scanner can differentiate layers within the retina and measure its thickness, thereby assisting in the early detection and diagnosis of diseases. Therefore, the rising demand for early diagnosis of diseases throughout the country will fuel the segment's growth.
Furthermore, the rising company activities in developing optical coherence tomography products and increasing product installations and launches in the country are also contributing to the market's growth. For instance, in September 2022, the Association of Optometrists of the United Kingdom announced that the Specsavers company had installed more than 1,000 optical coherence tomography (OCT) scanners across its practices in the United Kingdom and the Republic of Ireland. The source also claims that the growing use of OCT across the optometry sector has been essential in preventing sight loss in the United Kingdom. Due to the great precision and dependability of OCT scanners, it is anticipated that such initiatives will eventually draw a sizable number of individuals for eye exams. This will augment the market during the study period.
Thus, the factors mentioned above are expected to enhance segment growth significantly and contribute to the market growth over the forecast period.
The major factors driving the segment's growth are the rising prevalence of eye disorders, the increasing geriatric population, and activities by major players in the country.
The increasing prevalence of eye disorders such as myopia and hypermetropia are major factors driving the growing use of contact lenses. For instance, according to an article published by PLOS One in January 2022, a study showed that the overall frequency of primary myopia in the United Kingdom biobank population was 26.9%, which comprised 4.0% high myopia, 9.5% moderate, and 13.3% low myopia. Moreover, the increasing geriatric population coupled with the age-related loss of close-up vision is also expected to enhance segment growth.
Key developments by major market players are also driving the market's growth. For instance, in June 2021, Johnson & Johnson Vision launched its new reusable contact lens, “Acuvue Oasys Multifocal,” for patients with presbyopia in the United Kingdom.
Hence due to factors such as the increasing prevalence of eye disorders, the rising geriatric population, and key developments by major players, the contact lenses segment is expected to experience growth during the forecast period of the study.
This product will be delivered within 2 business days.
The COVID-19 pandemic affected healthcare systems and interrupted usual care in many healthcare facilities, exposing vulnerable patients to significant risks. The pandemic significantly impacted the ophthalmology devices market. For instance, according to a study published by the British and Irish Orthoptic Journal in March 2021, it was observed that during the first peak of the pandemic, outpatient clinic appointments were reduced by 87.2%, ophthalmic surgery by 90.9%, outpatient referrals to ophthalmology by 50.2%, and ward reviews by 50%. In addition, as per the same source, 1,377 canceled appointments were recorded, and 6.8% of those were deemed teleophthalmology-eligible. Thus, the COVID-19 pandemic severely curtailed the ophthalmology service's clinical activity. In the post-pandemic period, routine ophthalmic procedures are being normally conducted. Hence the market studied is expected to have stable growth during the forecast period of the study.
Certain factors propelling the market growth are demographic shifts, the increasing prevalence of eye diseases, and technological advancements in ophthalmic devices. For instance, an article published by Eye Journal in October 2021 stated that when a prospective cross-sectional study was carried out on participants in homeless shelters in Cardiff, United Kingdom, the findings indicated a significant disparity in ocular health, visual acuity, and refractive error amongst the homeless in comparison with the general population. The burden of eye diseases among the target population is expected to raise the demand for early diagnosis, which is likely to increase the demand for ophthalmology devices, thereby boosting market growth.
Furthermore, according to the data from the Association of British Dispensing Opticians (ABDO) in October 2022, ophthalmology was the busiest outpatient specialty in the NHS of the United Kingdom, and almost 633,000 people were waiting for NHS ophthalmology appointments in May 2022. The source also stated that more than 2 million people are at risk of vision loss due to glaucoma. An estimated 1,390,000 people are living with ocular hypertension, and a further 708,000 are living with glaucoma in the United Kingdom in 2022. Hence, the high prevalence of eye disorders in the United Kingdom and its rising burden is expected to enhance the market growth.
Moreover, key developments by major market players are also boosting market growth. For instance, in November 2021, Grafton Optical, a United Kingdom-based company, launched two new ophthalmic devices FundusVue camera and the NFC-600 non-mydriatic retinal camera. The NFC-600 non-mydriatic retinal camera’s key features include high-quality retinal images, portability, and connectivity. The FundusVue non-mydriatic fundus camera is designed to aid practitioners in diagnosing retinal diseases such as diabetic retinopathy, age-related macular degeneration (AMD), and glaucoma. Furthermore, in July 2021, Johnson & Johnson Vision introduced VERITAS Vision System, next-generation phacoemulsification (phaco) system designed to address three critical areas: patient safety, surgeon efficiency, and comfort in Europe, including the United Kingdom.
Hence, factors such as the rising prevalence of ophthalmic disorders and increasing key developments by major market players are boosting market growth. However, the risk associated with ophthalmic procedures is likely to restrain the market growth.
UK Ophthalmology Devices Market Trends
Optical Coherence Tomography Scanners under Diagnostic and Monitoring Devices Segment is Expected to Register Significant CAGR over the Forecast Period
Optical coherence tomography (OCT) imaging is a rapid, safe, and non-invasive procedure and is increasingly being recognized as the gold standard for diagnosing retinal disease. OCT uses light waves to take cross-section pictures of the retina. They also provide treatment guidance for glaucoma and conditions of the retina. These retinal diseases include age-related macular degeneration (AMD) and diabetic eye disease.The optical coherence tomography (OCT) segment in the market studied is expected to be driven due to the growing burden of glaucoma and retinal diseases and the rising focus of key players. For instance, according to the statistics published by Glaucoma UK, in the International Glaucoma Association Report and Financial Statements year ended 31st July 2021, it was predicted that the number of people living with glaucoma will increase by 31% in the United Kingdom by 2035. Additionally, as per the article published by City, University of London, in May 2022, glaucoma affected around 2% of people aged over 40 years and almost 10% of those over 75 years, leading to more than a million hospital visits every year. Thus, a significantly high glaucoma burden on the country’s healthcare infrastructure is expected to drive the market. In addition, as per the same source, optical coherence tomography (OCT) scanner can differentiate layers within the retina and measure its thickness, thereby assisting in the early detection and diagnosis of diseases. Therefore, the rising demand for early diagnosis of diseases throughout the country will fuel the segment's growth.
Furthermore, the rising company activities in developing optical coherence tomography products and increasing product installations and launches in the country are also contributing to the market's growth. For instance, in September 2022, the Association of Optometrists of the United Kingdom announced that the Specsavers company had installed more than 1,000 optical coherence tomography (OCT) scanners across its practices in the United Kingdom and the Republic of Ireland. The source also claims that the growing use of OCT across the optometry sector has been essential in preventing sight loss in the United Kingdom. Due to the great precision and dependability of OCT scanners, it is anticipated that such initiatives will eventually draw a sizable number of individuals for eye exams. This will augment the market during the study period.
Thus, the factors mentioned above are expected to enhance segment growth significantly and contribute to the market growth over the forecast period.
Contact Lenses Segment is Expected to Hold a Significant Market Share Over the Forecast Period
Contact lenses are used for correcting vision. They can correct several eye disorders, such as nearsightedness, farsightedness, astigmatism, age-related loss of close-up vision, and irregular corneal curvature (keratoconus). They are more comfortable to wear than traditional gas-permeable lenses.The major factors driving the segment's growth are the rising prevalence of eye disorders, the increasing geriatric population, and activities by major players in the country.
The increasing prevalence of eye disorders such as myopia and hypermetropia are major factors driving the growing use of contact lenses. For instance, according to an article published by PLOS One in January 2022, a study showed that the overall frequency of primary myopia in the United Kingdom biobank population was 26.9%, which comprised 4.0% high myopia, 9.5% moderate, and 13.3% low myopia. Moreover, the increasing geriatric population coupled with the age-related loss of close-up vision is also expected to enhance segment growth.
Key developments by major market players are also driving the market's growth. For instance, in June 2021, Johnson & Johnson Vision launched its new reusable contact lens, “Acuvue Oasys Multifocal,” for patients with presbyopia in the United Kingdom.
Hence due to factors such as the increasing prevalence of eye disorders, the rising geriatric population, and key developments by major players, the contact lenses segment is expected to experience growth during the forecast period of the study.
UK Ophthalmology Devices Market Competitor Analysis
The United Kingdom's ophthalmology devices market is highly fragmented owing to the presence of more market players. The market players focus on continuous product development and offer ophthalmology devices at competitive prices, especially in developing countries. Some of the major players include IRIDEX Corporation, Ziemer Ophthalmic Systems AG, Alcon, Johnson & Johnson, Cooper Vision Inc., Bausch & Lomb, Carl Zeiss AG, Topcon Corporation, and Nidek Co. Ltd, among others.Additional benefits of purchasing the report:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
This product will be delivered within 2 business days.
Table of Contents
1 INTRODUCTION
4 MARKET DYNAMICS
5 MARKET SEGMENTATION (Market Size Value in USD Million)
6 COMPETITIVE LANDSCAPE
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Alcon Inc.
- Bausch Health Companies Inc.
- Carl Zeiss Meditec AG
- HAAG-Streit Group (Metall Zug AG)
- IRIDEX Corporation
- Johnson and Johnson
- Nidek Co. Ltd
- Topcon Corporation
- CooperVision
- Ziemer Ophthalmic Systems AG
Methodology
LOADING...
